Jieling Jiang Selected Research

Jieling Jiang Research Topics

3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023
1	Neoplasms (Cancer) 11/2023
1	Fever (Fevers) 01/2022
1	Fever of Unknown Origin 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2020
1	Inflammation (Inflammations) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2019
1	Leukemia 04/2017

3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 01/2019
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2020 - 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	CytokinesIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Cladribine FDA LinkGeneric 01/2022
1	thymoglobulin FDA Link 03/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2020
1	fludarabineIBA 03/2020
1	NF-E2-Related Factor 2IBA 01/2020
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 04/2019
1	Rituximab (Mabthera)FDA Link 04/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2017

3	Stem Cell Transplantation 04/2024 - 03/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2019
2	Transplantation 01/2022 - 01/2022
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2019 - 01/2019
1	Radiofrequency Ablation 09/2021
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Therapeutics 04/2017